Search results for: 'Automation and Software Solutions'

21 Jun 2018  |  North America  |  Market Research

Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022

Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations

Infographics

×

Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...

28 Jun 2024  |  Global  |  Market Research

Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029

A Steady Increase in Laboratory Budgets in Academia is Driving Innovation

Infographics

×

This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...

Endoscope reprocessing systems and workflow solutions was a €416.4 million market in the top five Western European countries (UK, Germany, France, Spain, and Italy) in 2017. It is expected to grow at a robust CAGR of 9.5% to reach a revenue of €654.9 million by 2022. The market is segmented into two broad segments which are then divided into severa...

10 Sep 2024  |  Global  |  Technology Research

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

Infographics

×

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...

Clinical diagnostics, life science research, genomics and proteomics, and drug discovery labs are adopting lab automation solutions to overcome tremendous operational pressure because of the demand for high throughput and shortage of technicians. Solutions that automate pre-analytical, analytical, and post-analytical processes are available. The re...

Numerous facilities, ranging from research laboratories to hospitals, academic centers and commercial entities, collect human tissues and biomaterials. This study will discuss opportunities, challenges and forecasts for the biobanking automation market globally for the period 2010-2018. Varying requirements of biobanks have urged market participant...

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, intelligent laboratory ecosystems enabled by robotics,...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

24 Jan 2023  |  North America  |  Market Research

US Healthcare Claims Management Growth Opportunities

Intelligent Tools to Automate Payer and Provider Functions Will Boost Efficiency and Deliver a Digital Customer Experience

Infographics

×

The healthcare claims management industry is evolving. Changes include a shifting reimbursement landscape (for virtual care, urgent care, telehealth, and at-home care); a transition to new, value-based care models (e.g., population-based reimbursement and partial and full capitation payment); and disruption from big tech companies, big-box retailer...